Zobrazeno 1 - 10 of 53 pro vyhledávání: '"Latiano TP"'
2
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX
Autor: Francesco Sponziello, Saverio Cinieri, Giuseppe Grimaldi, Alessandra Cassano, M. Biglietto, Pietro Micheli, Gianni Simone, C. Barone, Fabiana Tatangelo, Antonella Marino, Giacomo Cartenì, Guglielmo Nasti, D. Rizzi, Antonio Febbraro, Cinzia Chiarazzo, Mario Manusia, Vito Lorusso, Fortunato Ciardiello, A.R. Bordonaro, S. Romito, Sabrina Rossi, Teresa Troiani, F. De Vita, Eugenio Tommaselli, Giuseppe Colucci, Andrea Onetti Muda, Guido Giordano, Luigi Leo, G. Modoni, Annamaria Sebastio, Sandro Barni, Francesco Giuliani, Paolo Graziano, M. Rachiglio, Michele Aieta, Evaristo Maiello, Enrica Martinelli, Mirko Montrone, Silvana Leo, Tiziana Latiano, Stefano Cordio, Laura Longhitano, Vincenzo Rosario Iaffaioli, Vincenzo Montesarchio, Nicola Normanno, Anna Nappi, Matilde Lambiase, Gerardo Botti, Gabriele Di Maggio, Giuseppe Tonini, Nicoletta Chicchinelli, Oscar Nappi, Claudia Cardone, Michele Orditura, A. Rinaldi, Salvatore Pisconti, Tiziana Guarino
Background Cetuximab plus chemotherapy is a first-line treatment option in metastatic KRAS and NRAS wild-type colorectal cancer (CRC) patients. No data are currently available on continuing anti-epidermal growth factor receptor (EGFR) therapy beyond
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343fea2703fb6409297f48937f6f6bde
http://hdl.handle.net/11591/354385
Zobrazit plný text záznamu
3
Akademický článek
Detecting BRAF mutations in colorectal cancer in clinical practice: an Italian experts' position paper.
Autor: Malapelle U; Department of Public Health, University Federico II of Naples, Naples, Italy., Angerilli V; Department of Medicine - DIMED, University of Padua, Padua, Italy., Intini R; Medical Oncology 1, Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Bergamo F; Medical Oncology 1, Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Cremolini C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Grillo F; IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Pathology Unit, Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy., Rocco EG; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Latiano TP; Medical Oncology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Martinelli E; Department of Precision Medicine, Oncology Unit, Università della Campania 'L. Vanvitelli', Naples, Italy., Normanno N; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori' Meldola, Italy., Pagni F; Department of Medicine and Surgery, Pathology, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy., Parente P; Pathology Unit, Fondazione IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG) Italy., Pastorino A; Medical Oncology Unit 1, Ospedale Policlinico San Martino - IRCCS, Largo Rosanna Benzi 10, 16132 Genoa, Italy., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Salvatore L; Medical Oncology, Università Cattolica del Sacro Cuore, Rome, Italy; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS Rome, Italy., Lonardi S; Department of Oncology, Veneto Institute of Oncology IRCCS, Padua, Italy., Fassan M; Department of Medicine - DIMED, University of Padua, Padua, Italy; Veneto Institute of Oncology IOV - IRCCS, Padua, Italy. Electronic address: matteo.fassan@unipd.it.
Publikováno v: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 Nov 22, pp. 104574. Date of Electronic Publication: 2024 Nov 22.
Zobrazit plný text záznamu
4
Akademický článek
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF V600E wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial.
Autor: Ciardiello D; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS, Milan., Boscolo Bielo L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan., Napolitano S; Department of Precision Medicine, The University of Campania Luigi Vanvitelli, Naples., Martinelli E; Department of Precision Medicine, The University of Campania Luigi Vanvitelli, Naples., Troiani T; Department of Precision Medicine, The University of Campania Luigi Vanvitelli, Naples., Nicastro A; Department of Precision Medicine, The University of Campania Luigi Vanvitelli, Naples., Latiano TP; Medical Oncology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo., Parente P; Pathology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo., Maiello E; Medical Oncology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo., Avallone A; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples., Normanno N; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Mendola., Pisconti S; Medical Oncology Unit, San Giuseppe Moscati Hospital, Statte., Nisi C; Medical Oncology Unit, San Giuseppe Moscati Hospital, Statte., Bordonaro R; Medical Oncology Unit, Azienda Ospedaliera ARNAS Garibaldi, Catania., Russo AE; Medical Oncology Unit, Azienda Ospedaliera ARNAS Garibaldi, Catania., Tamburini E; Department of Oncology and Palliative Care, Cardinale G Panico, Tricase City Hospital, Tricase., Toma I; Department of Oncology and Palliative Care, Cardinale G Panico, Tricase City Hospital, Tricase., Lotesoriere C; Medical Oncology Unit, National Institute of Gastroenterology, IRCCS de Bellis Research Hospital, Castellana Grotte, Italy., Vallarelli S; Medical Oncology Unit, National Institute of Gastroenterology, IRCCS de Bellis Research Hospital, Castellana Grotte, Italy., Zampino MG; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS, Milan., Fazio N; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS, Milan., Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan., De Vita F; Department of Precision Medicine, The University of Campania Luigi Vanvitelli, Naples., Ciardiello F; Department of Precision Medicine, The University of Campania Luigi Vanvitelli, Naples. Electronic address: fortunato.ciardiello@unicampania.it., Martini G; Department of Precision Medicine, The University of Campania Luigi Vanvitelli, Naples.
Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Aug 29. Date of Electronic Publication: 2024 Aug 29.
Zobrazit plný text záznamu
5
Akademický článek
Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers.
Autor: Tavano F; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza' Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy., Latiano A; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza' Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy., Palmieri O; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza' Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy., Gioffreda D; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza' Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy., Latiano T; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza' Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy., Gentile A; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza' Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy., Tardio M; Department of Surgery, Fondazione IRCCS 'Casa Sollievo della Sofferenza' Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy., Latiano TP; Department of Oncology, Fondazione IRCCS 'Casa Sollievo della Sofferenza' Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy., Gentile M; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza' Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy., Terracciano F; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza' Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy., Perri F; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza' Hospital, Viale Cappuccini 1, 71013 San Giovanni Rotondo, FG, Italy.
Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 02; Vol. 25 (15). Date of Electronic Publication: 2024 Aug 02.
Zobrazit plný text záznamu
6
Akademický článek
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study.
Autor: Pinto C; Medical Oncology, Comprehensive Cancer Centre Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Orlandi A; Comprehensive Cancer Center, UOC Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy., Normanno N; Translational Research Departement, Istituto Nazionale Tumori IRCCS-Fondazione G. Pascale, Napoli, Italy., Maiello E; Oncology Unit, Foundation IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Calegari MA; Comprehensive Cancer Center, UOC Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy., Antonuzzo L; Department of Experimental and Clinical Medicine, University of Florence, Italy Clinical Oncology Unit, Careggi University Hospital, Firenze, Italy., Bordonaro R; Medical Oncology, Azienda Ospedaliera ARNAS Garibaldi, Catania, Italy., Zampino MG; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IRCCS, Milan, Italy., Pini S; Ospedale Santa Maria delle Croci, Ravenna, Italy., Bergamo F; Dipartimento Oncologia 1, IOV-Istituto Oncologico Veneto IRCCS, Padova, Italy., Tonini G; Dipartimento di Oncologia, Fondazione Policlinico Campus Bio-Medico, Facoltà di Medicina Università Campus Bio-Medico, Rome, Italy., Avallone A; Medical Oncology, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, Naples, Italy., Latiano TP; Oncology Unit, Foundation IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Rosati G; Medical Oncology Unit, S. Carlo Hospital, Potenza, Italy., Cogoni AA; UO Oncologia AOU Sassari, Sassari, Italy., Ballestrero A; DiMI Università degli Studi di Genova e Ospedale Policlinico San Martino IRCCS, Genova, Italy., Zaniboni A; Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy., Roselli M; Medical Oncology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy., Tamberi S; UO Medical Oncology, Area Vasta Romagna Ausl di Ravenna, Presidio Ospedaliero di Faenza, Ospedale Civile degli Infermi, Faenza, Italy., Barone C; Comprehensive Cancer Center, UOC Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Apr 10; Vol. 42 (11), pp. 1278-1287. Date of Electronic Publication: 2024 Jan 05.
Zobrazit plný text záznamu
7
Akademický článek
A powerful machine learning approach to identify interactions of differentially abundant gut microbial subsets in patients with metastatic and non-metastatic pancreatic cancer.
Autor: Villani A; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Fontana A; Biostatistic Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Panebianco C; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Ferro C; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Copetti M; Biostatistic Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Pavlovic R; Proteomics and Metabolomics Facility (ProMeFa), IRCCS San Raffaele Scientific Institute, Milan, Italy., Drago D; Proteomics and Metabolomics Facility (ProMeFa), IRCCS San Raffaele Scientific Institute, Milan, Italy., Fiorentini C; Scientific Direction, Association for Research on Integrative Oncological Therapies (ARTOI), Roma, Italy., Terracciano F; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Bazzocchi F; Abdominal Surgery Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Canistro G; Abdominal Surgery Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Pisati F; Histopathology Unit, Cogentech S.C.a.R.L, Milan, Italy., Maiello E; Oncology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Latiano TP; Oncology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Perri F; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Pazienza V; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Publikováno v: Gut microbes [Gut Microbes] 2024 Jan-Dec; Vol. 16 (1), pp. 2375483. Date of Electronic Publication: 2024 Jul 07.
Zobrazit plný text záznamu
8
Akademický článek
Mucosal Microbiota from Colorectal Cancer, Adenoma and Normal Epithelium Reveals the Imprint of Fusobacterium nucleatum in Cancerogenesis.
Autor: Palmieri O; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza', 71013 San Giovanni Rotondo, Italy., Castellana S; Unit of Bioinformatics, Fondazione IRCCS 'Casa Sollievo della Sofferenza', 71013 San Giovanni Rotondo, Italy., Latiano A; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza', 71013 San Giovanni Rotondo, Italy., Latiano T; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza', 71013 San Giovanni Rotondo, Italy., Gentile A; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza', 71013 San Giovanni Rotondo, Italy., Panza A; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza', 71013 San Giovanni Rotondo, Italy., Nardella M; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza', 71013 San Giovanni Rotondo, Italy., Ciardiello D; Division of Oncology, Fondazione IRCCS 'Casa Sollievo della Sofferenza', 71013 San Giovanni Rotondo, Italy.; Division of Medical Oncology, Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80131 Naples, Italy., Latiano TP; Division of Oncology, Fondazione IRCCS 'Casa Sollievo della Sofferenza', 71013 San Giovanni Rotondo, Italy., Corritore G; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza', 71013 San Giovanni Rotondo, Italy., Mazza T; Unit of Bioinformatics, Fondazione IRCCS 'Casa Sollievo della Sofferenza', 71013 San Giovanni Rotondo, Italy., Perri F; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza', 71013 San Giovanni Rotondo, Italy., Biscaglia G; Division of Gastroenterology and Endoscopy, Fondazione IRCCS 'Casa Sollievo della Sofferenza', 71013 San Giovanni Rotondo, Italy.
Publikováno v: Microorganisms [Microorganisms] 2023 Apr 28; Vol. 11 (5). Date of Electronic Publication: 2023 Apr 28.
Zobrazit plný text záznamu
9
Akademický článek
Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRAS G12D mutated pancreatic cancer in vivo model.
Autor: Panebianco C; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, Viale dei Cappuccini, 1, 71013, San Giovanni Rotondo, FG, Italy., Pisati F; Histopathology Unit, Cogentech S.C.a.R.L, FIRC Institute of Molecular Oncology (IFOM), Via Adamello, 16, 20139, Milan, MI, Italy., Villani A; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, Viale dei Cappuccini, 1, 71013, San Giovanni Rotondo, FG, Italy., Andolfo A; Proteomics and Metabolomics Facility (ProMeFa), IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy., Ulaszewska M; Proteomics and Metabolomics Facility (ProMeFa), IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy., Bellini E; Proteomics and Metabolomics Facility (ProMeFa), IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy., Ferro C; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, Viale dei Cappuccini, 1, 71013, San Giovanni Rotondo, FG, Italy., Lombardi R; Unit of Pharmacy, Department of Pharmaceuticals, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Orsenigo F; IFOM, FIRC Institute of Molecular Oncology, Milan, Italy., Latiano TP; Oncology Unit Fondazione IRCCS Casa Sollievo della Sofferenza, Viale dei Cappuccini, 1, 71013, San Giovanni Rotondo, FG, Italy., Belmonte B; Tumor Immunology Unit, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties 'G. D'Alessandro', University of Palermo, Via del Vespro 129, 90127, Palermo, Italy., Tripodo C; Histopathology Unit, Cogentech S.C.a.R.L, FIRC Institute of Molecular Oncology (IFOM), Via Adamello, 16, 20139, Milan, MI, Italy.; Tumor Immunology Unit, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties 'G. D'Alessandro', University of Palermo, Via del Vespro 129, 90127, Palermo, Italy., Perri F; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, Viale dei Cappuccini, 1, 71013, San Giovanni Rotondo, FG, Italy., Pazienza V; Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, Viale dei Cappuccini, 1, 71013, San Giovanni Rotondo, FG, Italy. pazienza_valerio@yahoo.it.
Publikováno v: Cell death discovery [Cell Death Discov] 2023 Apr 05; Vol. 9 (1), pp. 116. Date of Electronic Publication: 2023 Apr 05.
Zobrazit plný text záznamu
10
Akademický článek
Cetuximab as third-line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild-type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trials.
Autor: Martini G; Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania 'L. Vanvitelli', Naples, Italy., Ciardiello D; Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania 'L. Vanvitelli', Naples, Italy.; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy., Famiglietti V; Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania 'L. Vanvitelli', Naples, Italy., Rossini D; Medical Oncology, Azienda Ospedaliero-Universitaria, Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy., Antoniotti C; Medical Oncology, Azienda Ospedaliero-Universitaria, Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy., Troiani T; Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania 'L. Vanvitelli', Naples, Italy., Napolitano S; Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania 'L. Vanvitelli', Naples, Italy., Esposito L; Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania 'L. Vanvitelli', Naples, Italy., Latiano TP; Oncologia Medica, Ospedale Casa Sollievo della Sofferenza-IRCCS foundation, San Giovanni Rotondo, Italy., Maiello E; Oncologia Medica, Ospedale Casa Sollievo della Sofferenza-IRCCS foundation, San Giovanni Rotondo, Italy., Del Re M; Medical Oncology, Azienda Ospedaliero-Universitaria, Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy., Lonardi S; Medical Oncology, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Aprile G; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy., Santini D; Oncologia Medica, Univeristà La Sapienza-Polo Pontino, Rome, Italy., Masi G; Medical Oncology, Azienda Ospedaliero-Universitaria, Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy., Avallone A; Oncologia Medica, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione Giovanni Pascale' - IRCCS, Naples, Italy., Normanno N; Biologia Cellulare e Bioterapie, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione Giovanni Pascale' - IRCCS, Naples, Italy., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pinto C; Medical Oncology, Comprehensive Cancer Centre, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Ciardiello F; Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania 'L. Vanvitelli', Naples, Italy., Cremolini C; Medical Oncology, Azienda Ospedaliero-Universitaria, Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy., Martinelli E; Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania 'L. Vanvitelli', Naples, Italy.
Publikováno v: Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (8), pp. 9392-9400. Date of Electronic Publication: 2023 Mar 07.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje